Article metrics

Download PDFPDF
A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix: An NRG Oncology/Gynecologic Oncology Group Study

Statistics from

Online download statistics by month:

Online download statistics by month: January 2019 to October 2019

Jan 2019800
Feb 20193400
Mar 20195800
Apr 20192500
May 20192500
Jun 20191200
Jul 20193906
Aug 20191600
Sep 20193800
Oct 2019400